Myeloid-Derived Suppressor Cells: A Propitious Road to Clinic

Volume: 11, Issue: 11, Pages: 2693 - 2706
Published: Oct 11, 2021
Abstract
Myeloid-derived suppressor cells (MDSC) are important regulators of immune responses in cancer. They represent a relatively stable form of pathologic activation of neutrophils and monocytes and are characterized by distinct transcriptional, biochemical, functional, and phenotypical features. The close association of MDSCs with clinical outcomes in cancer suggests that these cells can be an attractive target for therapeutic intervention. However,...
Paper Details
Title
Myeloid-Derived Suppressor Cells: A Propitious Road to Clinic
Published Date
Oct 11, 2021
Volume
11
Issue
11
Pages
2693 - 2706
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.